Reshma Kewalramani - Jun 24, 2022 Form 4/A - Amendment Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
CEO & President, Director
Signature
/s/ Joy Liu, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Jun 24, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/21/2022, 04:45 PM
Date Of Original Report
Jun 28, 2022
Previous filing
Jun 13, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VRTX Common Stock 111K Jun 24, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 filed by Dr. Kewalramani on June 28, 2022 inadvertently excluded 134 shares acquired by Dr. Kewalramani under the issuer's Employee Stock Purchase Plan. This amendment reports all of the shares beneficially owned by Dr. Kewalramani following the transactions reported on the original Form 4.